An elegant model proposed by Koury and Bondurant (1992), explained the basis of differing EPO sensitivities as a built-in mechanism to prevent all erythroid precursors undergoing apoptosis during low EPO levels in circulation such as in patients with renal failure. This evidence concerns the gene EPO and kidney failure.